Skip to search formSkip to main contentSkip to account menu

Nesbuvir

Known as: 5-Cyclopropyl-2-(4-fluorophenyl)-6-((2-hydroxyethyl)(methylsulfonyl)amino)-N-methyl-1-benzofuran-3-carboxamide 
A non-nuceoside polymerase inhibitor with activity against hepatitis C virus (HCV). Nesbuvir binds to the palm site II pocket of HCV NS5B polymerase… 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

HCV 796

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Parallel Session Epidemiology VI QUANTIFYING ANTIVIRAL ACTIVITY OPTIMIZES DRUG COMBINATIONS AGAINST HEPATITIS C VIRUS INFECTION
With the introduction of direct-acting antivirals (DAAs), treatment against hepatitis C virus (HCV) has significantly improved… 
2017
2017
A profiling study of a newly developed HCVcc strain PR63cc's sensitivity to direct‐acting antivirals
2015
2015
A Novel , Selective Inhibitor of Hepatitis C Virus Targeted against the Viral RNA-Dependent RNA-Polymerase H Research
Hepatitis C virus, an enveloped positive – stranded RNA virus and the sole member of the genus Hepacivirus within the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)